Monday, September 22, 2025

No Result

View All Result

Home
Tech & Software
Earnings
Analysis
Trading & Momentum
Cryptocurrency
Banking & Insurance
AI & Quantum Computing

No Result

View All Result

No Result

View All Result

Home Tag IKT

Tag: IKT

Inhibikase Therapeutics Receives Buy Rating and Increased Price Target from HC Wainwright Co

by Elaine Mendonca

March 5, 2024

HC Wainwright & Co. has reiterated its Buy rating for Inhibikase Therapeutics (NASDAQ: IKT) on March 5, 2024, while raising ...

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Tag: IKT

Inhibikase Therapeutics Receives Buy Rating and Increased Price Target from HC Wainwright Co

Don't Miss It

Eli Lilly Faces FDA Scrutiny While Doubling Down on Manufacturing Expansion

Clearmind Medicines Groundbreaking Psychedelic Therapy Shows Promise in Treating Alcohol Use Disorder

Spire Wealth Management Shows Confidence in Churchill Downs Incorporated with New Acquisition and Bet on Future Growth

Categories

Popular News

Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations

Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize

Kraft Heinz Stock: A Contradiction in Market Sentiment

NextGen Healthcare Charts Course for Behavioral Health Transformation

Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies

Recommended

Berkshire Hathaway Concludes 17-Year BYD Investment with Complete Exit

Analysts Defend SAP’s Market Position Against Oracle Competition

Deutsche Bank Rejoins Europe’s Premier Index After Seven-Year Absence

Ethereum’s Quiet Ascent: The Calm Before the Next Rally

Espionage Scandal Rocks Austrian Energy Giant OMV

Recent News

Category

Tag: IKT

Don't Miss It

Categories

Browse by Tag

Popular News

Recommended

Recent News

Category